Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a)

Open access
Zhang, Wei, Speiser, Jaime Lynn, Ye, Fan, Tsai, Michael Y., Cainzos-Achirica, Miguel, Nasir, Khurram, Herrington, David M., Shapiro, Michael D. · 2021 · Journal of the American College of Cardiology

Abstract

Background Little is known about the relationship between lipoprotein (a) (Lp[a]) and high-sensitivity C-reactive protein (hsCRP) and their joint association with atherosclerotic cardiovascular disease (ASCVD). Objective To assess whether Lp(a)-associated ASCVD risk is modified by hsCRP in the context of primary prevention. Methods The current study included 4,679 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) Apolipoprotein ancillary dataset. Cox proportional hazards models and Kaplan-Meier curves were used to assess the association between Lp(a), hsCRP, and time to CVD events. Results During a mean follow up of 13.6 years, 684 CVD events occurred. A significant interaction was observed between Lp(a) and hsCRP (P=0.04). With hsCRP < 2 mg/L, no significant CVD riskwas observed at any level of Lp(a) from < 50 mg/dL to above 100 mg/dL. However, with hsCRP ≥ 2 mg/L, a significant CVD risk was observed with Lp(a) of 50 to 99.9 mg/dL (HR, 1.36; 95%CI, 1.02–1.81) and Lp(a) ≥ 100 mg/dL (HR, 2.09; 95%CI, 1.40–3.13). Isolated elevations of either Lp(a) or hsCRP were not associated with increased CVD risk. In contrast, the combination of elevated Lp(a) (≥ 50 mg/dL) and hsCRP (≥ 2 mg/L) was independently associated with significant CVD risk (HR, 1.62; 95%CI, 1.25–2.10) and all-cause mortality (HR, 1.39; 95%CI, 1.12–1.72). Conclusions Lp(a)-associated ASCVD risk is observed only with concomitant elevation of hsCRP. Individuals with concomitant presence of elevated Lp(a) and systemic inflammation have greater ASCVD risk and all-cause mortality, thus may merit closer surveillance and more aggressive ASCVD risk management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2021.07.016

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 169

Metadata

Authors
Zhang, W., Speiser, J. L., Ye, F., Tsai, M. Y., Cainzos-Achirica, M., Nasir, K., Herrington, D. M., & Shapiro, M. D.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2021-09
Volume
78
Issue
11
Pages
1083-1094
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3198763602
Cited by
169
References
15
FWCI
20.97
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a). https://app.cochat.ai/papers/10.1016/j.jacc.2021.07.016
The paper
Zhang, W., Speiser, J. L., Ye, F., Tsai, M. Y., Cainzos-Achirica, M., Nasir, K., Herrington, D. M., & Shapiro, M. D. (2021). High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a). Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2021.07.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.